Sallie Jo Hadley, MD

230 W 79th Street

New York, NY 10024
9178269952
2127122743 (F)
shd8745a@westpost.net
Professional Experience
Pfizer Inc
Clinical Director, Neuroscience
Global Medical Research and Development
New York, NY (2007-2009)
Mt Sinai School of Medicine
Assistant Professor, Psychiatry
New York, New York (2004-2007)
Psychiatrist (Private Practice (part-time))
New York, New York (2001-present)

Education/Training
Post-doctoral Clinical Research Training Fellowship (Child and Adolescent Psychi
atry)
Columbia University / New York State Psychiatric Institute
New York, NY (2002-2004)
Clinical Research Training Fellowship (Adult, Child and Adolescent Psychiatry)
Seaver Center for Research in Autism/Compulsive-Impulsive, Anxiety Disorder Rese
arch Program
Mt. Sinai School of Medicine
New York, NY (2000-2002)

Residency Training
Triple Board Residency Program (Pediatrics, Psychiatry, Child and Adolescent Psy
chiatry)
Mt. Sinai Medical Center, New York, NY (1995-2000)

Medical School Education

Mt. Sinai School of Medicine, New York, NY (1991-1995)
Doctor of Medicine, 1995

Undergraduate Education
University of North Carolina, Chapel Hill, NC (1977-1981)
B.S. Nursing, 1981

Licenses
New York State Education Department (Registered Physician 204720 (1996-present)
New York State Education Department (Registered Professional Nurse (1985-present
)
DEA certification (1996-present)

Board Certification and Eligibility

American Board of Psychiatry and Neurology (Certified 2003)
American Board of Pediatrics (Certified 1999)
Child and Adolescent Psychiatry (Eligible 2000; Passed written exam 2007; Oral b
oards- have not taken yet)

Awards/Prizes
Pfizer Global Medical Research and Development Individual Performance Award (200
9)
Pfizer Safety First Committee Award (2008)
Mount Sinai School of Medicine/Emory University Junior Faculty Award: "Future L
eaders of Psychiatry" Training Experience (May 3-6, 2007)
NIH Loan Forgiveness Program Recipient (Clinical Research) (2002-2003)
T32 (NIDA) National Research Service Award recipient (2001)
T32 (NIMH) National Research Service Award recipient (2000)
David and Gloria Schulman Prize in Psychiatry, Mount Sinai School of Medicine, N
ew York, New York (1995)

Sigma Theta Tau Nursing Honor Society, University of North Carolina, Chapel Hill
, NC (1981)

Publications
Hadley Sallie J., MD., Mandel Francine S, PhD; Schweitzer, Edward MD; Switching
From Long-Term Benzodiazepine Therapy to Pregabalin Patients with Generalized An
xiety Disorder: A Double-Blind, Placebo-Controlled Trial (2009, submitted for pu
blication)
Andrea Allen, PhD, Sallie Jo Hadley, MD, Alicia Kaplan, MD, Daphne Simeon, MD, J
ennifer Friedberg, PhD, Lauren Priday, MA, Bryann R. Baker, BA, Jennifer L. Gree
nberg, PsyM, and Eric Hollander, MD An Open-Label Trial of Venlafaxine in Body
Dysmorphic Disorder;. CNS Spectr. 2008; 13(2):138-14
Dell'Ossa, B. Hadley, SJ, Allen, A., Baker, B., Chaplin, W., Hollander, E: Escit
alopram in the Treatment of Internet Usage Disorder: an Open Label Trial Followe
d by a Double Blind Discontinuation Phase. CNS Spectr. 2007
Hadley, SJ, Kim, S, Priday, L.: Pharmacologic Treatment of Body Dysmorphic Disor
der. Primary Care Psychiatry, 2006, Vol.13 (7) 61-68.
Hadley, S.J., Walsh, B.T.: Gastrointestinal Disturbances in Anorexia Nervosa and
Bulimia Current Drug Targets. CNS & Neurological Disorders, 2003, Vol. 2 (1) 1-
9.
Hadley, S.J., Greenberg, J., Hollander, E.: Co-morbid Social Anxiety Disorder an
d Body Dysmorphic Disorder; adapted for Stand (Web Site Publishing Co) 2002. htt
p://www.actiondepression.net.
Hadley, S.J., Newcorn, J., Hollander, E.: Body Dysmorphic Disorder: Neurobiology
and Psychopharmacology in Phillips, K., Castle, D. (eds), Disorders of Body Ima
ge.Wrightson Biomedical Publishing, Hampshire, UK 2001 pp.139-155.
Hadley, S.J., Greenberg, J., Hollander, E.: Diagnosing and Treatment of Body Dys
morphic Disorder in Adolescents. Current Psychiatry Reports, (2001)108-113
Poster Presentations
Hadley Sallie J., MD., Mandel Francine S, PhD; Schweitzer, Edward MD (September,
2009). "Use of Pregabalin while Switching from Long-Term Benzodiazepine Therapy
in patients with Generalized Anxiety Disorder": Poster Presentation for the 22n
d annual congress of the European College of Neuropharmacology, Istanbul, Turkey
.
Hadley, S. Priday, L. (May, 2007). "Metabolic Monitoring among Outpatients Treat
ed with Atypical Antipsychotics". Poster Presentation, Society for Biological Ps
ychiatry Annual Meeting, San Diego, California.
Hadley, SJ, Priday, L., (May, 2007). "Preliminary Results from Metabolic Monitor
ing of Outpatient Psychiatric Patients Treated with Atypical Antipsychotics". Po
ster Presentation: Future Leaders of Psychiatry Conference. Emory University, At
lanta, Georgia
Hadley, S., Kim, S., Hollander (May, 2006) .Efficacy of Sertraline in the treatm
ent of Binge Eating Disorder among Overweight Children and Adolescents. Poster P
resentation, Society of Biological Psychiatry, Toronto, Ontario
Hadley, S, Baker, B. Hollander, E, (May, 2006). Escitalopram in the treatment of
Compulsive Use of the Internet. Poster Presented at the Society for Biological
Psychiatry, Toronto, Ontario.
Hadley, S.J. (May, 2006). "Balancing the Role of Clinician and Clinical Research
" Presentation at Center Wide Ethics Meeting, Mount Sinai Medical Center, New Yo
rk, New York.
Hadley, S. Baker, B., Hollander, E. (November, 2005) Escitalopram efficacy in th
e treatment of Compulsive Use of the Internet. . Poster presented at the 1st Ann
ual Meeting of the International Society for Research on Impulsivity, Washington
, DC.
Bartz, J., Fan, J., Martin, L., Baker, B., Kim, S., Dell'Osso, B., Hadley, S., S
imeon, D., Allen, A., & Hollander, E. (November,2005). fMRI Study of Reward Proc
essing in Pathological Gamblers. Poster Presented at the 1st Annual Meeting of t
he International Society for Research on Impulsivity, Washington, DC.

Detailed Clinical Research Experience (2000-2009)

Director, Neuroscience
Global Medical Research and Development New York, NY (2007-2009)
Pfizer Inc
Clinical Lead/ Clinician for Pfizer's mufti-disciplinary study teams responsible
for implementing phase 3b/4 global clinical trials. Provided medical perspectiv
e to study teams on decisions. monitored and reported adverse events, reviewed w
eekly labs, and reviewed data to assure site adherence to clinical trial protoco
ls. Assisted with database cleaning, querying sites for data discrepancies, esca
lated problems with studies to upper management, contributed to final study repo
rts and manuscripts. Specific clinical trials (delivered on time or ahead of sch
edule):
Safety and Efficacy of pregabalin vs. placebo in treatment of distal peripheral
neuropathic pain among subjects with HIV
Safety of open label pregabalin treatment of distal peripheral neuropathic pain
among subjects with HIV
Safety and Efficacy of pregabalin vs. placebo in treatment of central neuropathi
c pain among post-stroke subjects
Efficacy of pregabalin during withdrawal from benzodiazepines in subjects with G
eneralized Anxiety Disorder
Safety First Work Stream Committee Member / Representative for Neuroscience
Global Medical Research and Development
Pfizer Inc., New York, NY (2007-2009)
Led neuroscience clinicians in implementation of a new standard operating proced
ure for monitoring subject safety for all phase 3b/4 Pfizer sponsored clinical t
rials in neuroscience.
Principal Investigator/Research Attending
Mount Sinai Hospital, New York, New York (2005-2007)
Mt. Sinai Ambulatory Psychiatric Services Program (Adult, Geriatric, Child/Adole
scent, Day Treatment and Vocational Services)
Assessment of Risk Factors for Metabolic Syndrome, Diabetes and Cardiovascular D
isease among Psychiatric Clinic Outpatients receiving Atypical Antipsychotic Med
ications (2005-2007)
A Placebo-Controlled Study of Metformin Effectiveness in Counteracting Insulin R
esistance and Weight Gain in Patients Treated with Clozapine and Olanzapine (200
4)
A Multicenter Randomized Double Blind Study on the Effects of Aripiprazole on Ov
erweight Patients Treated With Olanzapine for Schizophrenia or Schizoaffective D
isorder (2005)
A Randomized Multicenter, Double Blind Placebo-Controlled Study of the Efficacy
and Safety of Aripiprazole in the Maintenance of Alcohol in Subjects with Alcoho
lism (2005-2006)

Sub-Investigator / Research Psychiatrist

Compulsive, Impulsive Anxiety Disorders Program
Mount Sinai School of Medicine, New York, NY (2004-2007)
PI: Eric Hollander, MD
Efficacy of Topiramate in the Treatment of Pathological Gambling
Serotonin Transporter Imaging using PET and MRI among adults with Pathological G
ambling
Efficacy of Topiramate in the Treatment of Obsessive Compulsive Disorder
Efficacy of Fluoxetine in the Treatment of Adolescent Body Dysmorphic Disorder
Cognitive Behavioral Therapy as an Adjunct to SRIs in Body Dysmorphic Disorder
Efficacy of Escitalopram in the Treatment of Internet Addiction
Efficacy of Sertraline in the Treatment of Obesity among Children and Adolescent
s with Binge Eating Disorder
Efficacy of Topiramate among Obese Adults with Binge Eating Disorder Use of TMS
for Refractory Patients with OCD
Neurocognition and Temperament Across Impulsive, Compulsive, and Autism Spectrum
Disorders
Sub-Investigator / Research Psychiatrist
Seaver Autism Research Center
Mount Sinai School of Medicine, New York, NY (2005-2007)
PI: Eric Hollander, MD
Efficacy and Safety of Aripiprazole in the treatment of Autism
Studies to Advance Autism Research (STAART)
Liquid Fluoxetine vs. Placebo in Preschool Age Children with Autism
Sub-investigator / Study Psychiatrist
Attention Deficit Hyperactivity Disorder Research Program
Child and Adolescent Psychiatry
Mount Sinai School of Medicine, New York, NY (2006-2007)
PI: Jeffrey Newcorn, MD
Methylphenidate vs. Atomoxetine in the treatment of Child and Adolescent Attenti
on-Deficit Hyperactivity Disorder
Institutional Review Board Member
Mount Sinai School of Medicine
New York, NY (2006-2007)
Reviewed submissions of clinical trial protocols, presented issues concerning su
bject safety or clinical trial design to IRB, reviewed, documented and discussed
protocol issues prior to voting to approve initial or continuation of funded st
udies conducted at Mount Sinai School of Medicine.
Clinical Research Training Fellow; Research Psychiatrist
Child and Adolescent Post-doctoral Clinical Research Fellowship Program
Columbia University, New York State Psychiatric Institute
Eating Disorder Research Center; New York, NY (2002-2004)
PI: David Shaffer, Mentor: Tim Walsh, MD
Translational Research examining the underlying neurobiology of eating disorders
(anorexia nervosa, bulimia nervosa, binge-eating disorder and obesity)
Metabolic Effects of Atypical Antipsychotics among Inpatient Children and Adoles
cents during Long Term Hospitalization
Effects of a Structured Exercise Program on measures of metabolism and overall p
hysical health among inpatient children and adolescents receiving psychotropic m
edications
Clinical Research Training Fellow; Research Psychiatrist
Department of Psychiatry Post-Doctoral Clinical Research Fellowship Program
Mount Sinai School of Medicine
New York, NY (2000-2002)
Seaver Center for Autism Research/ Compulsive Impulsive Anxiety Disorder Researc
h Program
PI/ Mentor, Eric Hollander, MD
Trained in design and implementation of federally and industry sponsored clinica
l trials investigating the safety and efficacy of various psychotropics (fluoxet
ine, risperidone, olanzapine, valproic acid) in treatment of symptoms specific t
o Autism Spectrum Disorders (adults, children and adolescents)
Trained in grant writing, manuscript writing as well as the design and implement
ation of federally and industry funded clinical trials investigating the efficac
y of various medications for symptoms specific to Obsessive-Compulsive Disorder,
Body Dysmorphic Disorder, Internet Addiction, Binge Eating Disorder, Tourette's
syndrome, and Pathological Gambling

Detailed Clinical Experience (2000-2010)

Psychiatrist (part-time, private practice)
New York, NY (2007-present)
Provide continuation of psychopharmacological treatments for individuals sufferi
ng symptoms related to autism, obsessive-compulsive disorder, body dysmorphic di
sorder, generalized anxiety disorder, mood disorders and impulse control disorde
rs.
Voluntary Attending, Psychiatry
Mount Sinai School of Medicine
New York, NY (2007-present)
Attending Psychiatrist
Faculty Practice Associates
Mt Sinai School of Medicine, New York, NY (2004-2007)
Psychopharmacological treatment of symptoms specific to autism, obsessive-compul
sive disorder, body dysmorphic disorder, generalized anxiety disorder and impuls
e control disorders.

Cognitive-Behavioral Therapist (CBT)

Columbia University/New York State Psychiatric Institute
Eating Disorder Research Program
New York, NY (2002-2004)
Supervisor: Michael Devlin, MD
Provided 20 weeks of structured CBT with post-session supervision to several res
earch subjects following their participation in clinical trials investigating bi
nge-eating disorder and obesity
On-Call Psychiatrist
New York State Psychiatric Institute
Inpatient Eating Disorder Research Unit
New York, NY (2002-2004)
Training Fellow Psychiatrist
Mt. Sinai School of Medicine (1st fellowship)
Department of Psychiatry
Seaver Autism Center/ Compulsive-Impulsive Anxiety Program
Mentor: Eric Hollander, MD
New York, NY (2000-2002)
Provided psychiatric care for individuals with obsessive-compulsive disorder, bo
dy dysmorphic disorder, or autism spectrum disorders who were ineligible for par
ticipation in clinical trials
Social Skills Group Co-leader (children ages 5-6years)
Seaver Autism Center
Mount Sinai School of Medicine
New York, NY (2000-2002)
Psychiatrist (part-time)
Neuropharmacology Services
New York, NY (2001-2006)
Supervisor/Mentor, Eric Hollander, MD
Conducted psychiatric evaluations, medication monitoring, psychiatric consultati
ons regarding pharmacological treatment options for children, adolescents and ad
ults with symptoms of obsessive-compulsive disorder, body dysmorphic disorder, o
r autism spectrum disorders.

Detailed Teaching/Clinical Supervision Experience (2000-2007)

Mt Sinai School of Medicine
Child and Adolescent Psychiatry Fellowship Didactic Program
New York, NY (2004-2007)
Lectured on medication treatments of anxiety, obsessive-compulsive spectrum and
autism spectrum disorders (2004-2007)
Medication Supervisor
Mount Sinai Hospital Ambulatory Psychiatry Medication Clinics
New York, NY (2004-2007)
Weekly supervision of several psychiatry residents, clinicians of permanent staf
f and child psychiatry fellows during their medication treatment of outpatients
followed in the ambulatory psychiatry division.
Metabolic Monitoring Program Implementation Co-Director
Ambulatory Psychiatry Services (Adult, Child/Adolescent, Geriatric, Vocational S
ervices, Day Treatment Program)
Mount Sinai Ambulatory Psychiatry Clinics, New York, NY (2005-2007)
Developed, received funding and obtained buy in from administration, trainees
and staff to successfully roll out a pilot metabolic monitoring program within
all divisions of the ambulatory psychiatry department at Mount Sinai.
Medication Supervisor, Child and Adolescent Trauma Services
Mount Sinai School of Medicine, Child and Adolescent Psychiatry
New York, NY (2004)
Conducted medication evaluations or supervised fellows in evaluating outpatients
participating in the child and adolescent trauma services program.
Supervisor, Mount Sinai School Based Mental Health Program
New York, NY (2004)
Supervised social workers providing mental health services at four NYC public sc
hools.
Supervisor, Pediatric-Psychiatry Consultation-Liaison Rotation
Division of Child and Adolescent Psychiatry Fellowship Program
Columbia University/New York State Psychiatric Institute/Columbia University Med
ical Center
New York, NY (2002-2004)
Supervised child psychiatry fellows providing psychiatric consultations/treatmen
t recommendations for pediatric inpatients.
Medication Supervisor, Psychiatry Training Program
Mt Sinai School of Medicine
New York, NY (2001-2002)
Weekly meetings with individual trainees for medication management of outpatient
s.
Lecturer, Didactic Program in Psychopharmacology
Mt Sinai School of Medicine
New York, NY (2001-2002)
Lectured on Pharmacological treatment options for Eating Disorders, Obsessive-Co
mpulsive Disorder, Autism Spectrum Disorders (2002)
Professional Nursing Experience (1981-1990)
Utilization Review, Psychiatry
Empire Blue Cross/Blue Shield
New York, NY (1986-1990)
Quality Assurance/ Nurse Reviewer of inpatient psychiatric hospitalizations (rev
iew of medical records, phone reviews with treating psychiatrists) to assure med
ical necessity for subscribers admitted to inpatient psychiatric hospitals. Revi
ewed medical records and discussed continued stays with treating clinicians to a
ssure medical necessity of inpatient hospitalization.
Nurse Reviewer spokesperson/liaison to Blue Cross computer programming consulta
nts developing an electronic method for conducting medical necessity reviews of
inpatient hospitalizations.

Computer Instructor
Empire Blue Cross/Blue Shield
New York, NY (1986-1988)
Taught nurse reviewers (locally and nationwide) to use the electronic documentat
ion process when conducting reviews of inpatient psychiatric hospitalizations
for medical necessity.
Psychiatric Nurse/Charge Nurse/Geriatric Psychiatry Group Co-leader
Durham Country General Hospital
Inpatient Psychiatry
Durham, NC (1983-86)
Provided inpatient psychiatric nursing care to adolescents and adults admitted t
o a private voluntary locked psychiatric unit.
Charge Nurse/Staff Nurse
North Carolina Memorial Hospital
Inpatient Acute Care Psychiatric Unit
Chapel Hill, NC (1983-1985)
Provided and supervised the acute care and stabilization of involuntarily hospit
alized adults on a locked state psychiatric unit.
Staff Nurse
Duke University Medical Center
Durham, NC (1981-83)
Neonatal Intensive Care Unit
Provided nursing care to critically ill infants in the ICU.
Volunteer On-call Hospice Nurse
Orange County Hospice (1981-1985)
Chapel Hill, Durham NC
Provided nursing and supportive care to terminally ill patients and their famili
es during patient's involvement